These results suggest that targeting CD36 by piceatannol or epicatechin can inhibit RA-FLS proliferation and TNF-α-induced inflammatory response, and promote cell cycle arrest and apoptosis. This evidence concerns the gene TNF and rheumatoid arthritis.